TRAJ47: A Protein Regulating T Cell Response (G28708)

Target Name: TRAJ47

NCBI ID: G28708

TRAJ47

Other Name(s): T cell receptor alpha joining 47

TRAJ47: A Protein Regulating T Cell Response

T cell receptor alpha joining 47 (TRAJ47) is a protein that is expressed in T cells, a type of white blood cell that plays a crucial role in the immune system. T cells are responsible for recognizing and responding to foreign substances in the body, such as viruses and bacteria. When a T cell encounters a foreign substance, it recognizes it through the T cell receptor alpha joining 47 protein.

The T cell receptor alpha joining 47 protein is a type of transmembrane protein that is composed of two extracellular domains and an intracellular domain. The extracellular domains of the protein are involved in cell-cell and cell-solute interactions, while the intracellular domain is involved in protein-protein interactions. The protein is also known as CD73, and it is a member of the immune globulin (Ig) family.

TRAJ47 is a 21-kDa protein that is expressed in T cells, B cells, and natural killer cells. It is located in the cytoplasm of these cells and plays a role in the regulation of the immune response.

One of the functions of TRAJ47 is to regulate the activation and proliferation of T cells. When a T cell encounters an antigen that it recognizes through its T cell receptor, it becomes activated and begins to divide. The activation of the T cell is regulated by the presence of several factors, including the cytokine environment and the level of co-stimulation by other cytokines.

TRAJ47 is also involved in the regulation of the cytokine environment. When a T cell is activated, it produces a variety of cytokines, such as interferon-gamma (IFN-纬), which is involved in the regulation of inflammation and immune responses. The The cytokine environment is regulated by the levels of nutrients available in the body, including the levels of glucose and amino acids.

TRAJ47 is also involved in the regulation of cell-solute interactions. When a T cell is activated, it produces a variety of enzymes that are involved in the production of intracellular signaling molecules, such as phosphatidylserine (PS) and src-tyrosine kinase (src -TK). These signaling molecules are involved in the regulation of cellular processes, including the migration and adhesion of T cells.

TRAJ47 is also involved in the regulation of protein-protein interactions. When a T cell is activated, it produces a variety of proteins that are involved in protein-protein interactions, including the protein tyrosine phosphatase (PTP). This protein is involved in the regulation of the signaling molecules that are produced by the T cell, including PTP.

In conclusion, T cell receptor alpha joining 47 (TRAJ47) is a protein that is involved in the regulation of the immune response. It is expressed in T cells, B cells, and natural killer cells, and it plays a role in the regulation of the activation and proliferation of these cells. It is also involved in the regulation of the cytokine environment, cell-solute interactions, and protein-protein interactions. As a result, TRAJ47 may be a drug target or biomarker for the development of new treatments for a variety of autoimmune and other diseases.

Protein Name: T Cell Receptor Alpha Joining 47

The "TRAJ47 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRAJ47 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets